About: covid:PMC7303568

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7303568 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Jafari, Ramezan Ghanei, Mostafa Izadi, Morteza Saadat, Seyed Azadi, Hossein Darabi, Enayat Fathi, Saeid Ghazvini, Ali Movaseghi, Fatemeh Mozafari, Abolfazl Panahi, Yunes Ranjkesh, Mohammad Rezapour, Mohammad Salesi, Mahmood Vahedi, Ensieh Zand, Nahid Ghazale, Amir Parsaei, Mohammadreza
is schema:about of	named entity 'clinical' named entity 'CENTERED' named entity 'SUFFERING' named entity 'observational study' named entity 'combination regimen' named entity 'naproxen' named entity 'levofloxacin' named entity 'pathophysiological' named entity 'corticosteroid therapy' named entity 'COVID' named entity 'demographic data' named entity 'SpO2' named entity 'dyspnea' named entity 'CRP' named entity 'lopinavir/ritonavir' named entity 'immune responses' named entity 'CRP' named entity 'COVID-19' named entity 'methylprednisolone' named entity 'respiratory failure' named entity 'hyperinflammation' named entity 'combination regimen' named entity 'meropenem' named entity 'diabetic patients' named entity 'ARDS' named entity 'CRP' named entity 'arbidol' named entity 'COVID' named entity 'TNF' named entity 'innate immunity' named entity 'ALOS' named entity 'increasing pace' named entity 'immune response' named entity 'Iran' named entity 'COVID-19 test' named entity 'retrospective studies' named entity 'SpO2' named entity 'Iran' named entity 'fever' named entity 'DBP' named entity 'Iran' named entity 'anti-inflammatory' named entity 'SpO2' named entity 'CT scan' named entity 'DBP' named entity 'virally' named entity 'COVID-19' named entity 'COVID' named entity 'virus' named entity 'dry cough' named entity 'real-time RT-PCR' named entity 'naproxen' named entity 'azithromycin' named entity 'hydroxychloroquine' named entity 'statistically significant' named entity 'combination regimen' named entity 'lopinavir/ritonavir' named entity 'immunomodulatory' named entity 'therapeutic strategies' named entity 'lung' named entity 'COVID-19' named entity 'secretion' named entity 'fever' named entity 'diabetes' named entity 'COVID' named entity 'secondary endpoints' named entity 'immunosuppression' named entity 'potency' named entity 'mortality rate' named entity 'antipyretic' named entity 'anti-inflammatory' named entity 'Macrolides' named entity 'lopinavir/ritonavir' named entity 'lung injury' named entity 'inflammation' named entity 'viral disease' named entity 'diastolic blood pressure' named entity 'short-term' named entity 'SARS-CoV' named entity 'SpO2' named entity 'medical records' named entity 'oxygen saturation'

Attributes

Values

Creator

Jafari, Ramezan
Ghanei, Mostafa
Izadi, Morteza
Saadat, Seyed
Azadi, Hossein
Darabi, Enayat
Fathi, Saeid
Ghazvini, Ali
Movaseghi, Fatemeh
Mozafari, Abolfazl
Panahi, Yunes
Ranjkesh, Mohammad
Rezapour, Mohammad
Salesi, Mahmood
Vahedi, Ensieh
Zand, Nahid
Ghazale, Amir
Parsaei, Mohammadreza

is schema:about of

named entity 'clinical'
named entity 'CENTERED'
named entity 'SUFFERING'
named entity 'observational study'
named entity 'combination regimen'
named entity 'naproxen'
named entity 'levofloxacin'
named entity 'pathophysiological'
named entity 'corticosteroid therapy'
named entity 'COVID'
named entity 'demographic data'
named entity 'SpO2'
named entity 'dyspnea'
named entity 'CRP'
named entity 'lopinavir/ritonavir'
named entity 'immune responses'
named entity 'CRP'
named entity 'COVID-19'
named entity 'methylprednisolone'
named entity 'respiratory failure'
named entity 'hyperinflammation'
named entity 'combination regimen'
named entity 'meropenem'
named entity 'diabetic patients'
named entity 'ARDS'
named entity 'CRP'
named entity 'arbidol'
named entity 'COVID'
named entity 'TNF'
named entity 'innate immunity'
named entity 'ALOS'
named entity 'increasing pace'
named entity 'immune response'
named entity 'Iran'
named entity 'COVID-19 test'
named entity 'retrospective studies'
named entity 'SpO2'
named entity 'Iran'
named entity 'fever'
named entity 'DBP'
named entity 'Iran'
named entity 'anti-inflammatory'
named entity 'SpO2'
named entity 'CT scan'
named entity 'DBP'
named entity 'virally'
named entity 'COVID-19'
named entity 'COVID'
named entity 'virus'
named entity 'dry cough'
named entity 'real-time RT-PCR'
named entity 'naproxen'
named entity 'azithromycin'
named entity 'hydroxychloroquine'
named entity 'statistically significant'
named entity 'combination regimen'
named entity 'lopinavir/ritonavir'
named entity 'immunomodulatory'
named entity 'therapeutic strategies'
named entity 'lung'
named entity 'COVID-19'
named entity 'secretion'
named entity 'fever'
named entity 'diabetes'
named entity 'COVID'
named entity 'secondary endpoints'
named entity 'immunosuppression'
named entity 'potency'
named entity 'mortality rate'
named entity 'antipyretic'
named entity 'anti-inflammatory'
named entity 'Macrolides'
named entity 'lopinavir/ritonavir'
named entity 'lung injury'
named entity 'inflammation'
named entity 'viral disease'
named entity 'diastolic blood pressure'
named entity 'short-term'
named entity 'SARS-CoV'
named entity 'SpO2'
named entity 'medical records'
named entity 'oxygen saturation'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software